Login / Signup

Pembrolizumab for advanced penile cancer: a case series from a phase II basket trial.

Andrew W HahnJad ChahoudMatthew T CampbellDaniel D KarpJennifer WangBettzy StephenShi-Ming TuCurtis A PettawayAung Naing
Published in: Investigational new drugs (2021)
ClinicalTrials.gov identifier: NCT02721732 . Registered March 23, 2016.
Keyphrases
  • phase ii
  • clinical trial
  • open label
  • phase iii
  • papillary thyroid
  • placebo controlled
  • squamous cell
  • double blind
  • study protocol
  • randomized controlled trial
  • lymph node metastasis
  • prostate cancer
  • childhood cancer